New targets to treat the structural remodeling of the myocardium

Area of Science:

• Cardiology
• Pathology
• Molecular Biology

Background:

• Current heart failure treatment focuses on predisposing factors and neurohumoral activation.
• Pathological structural remodeling of the myocardium is increasingly recognized as a therapeutic target.
• Chronic injury leads to cardiomyocyte and non-cardiomyocyte damage, including inflammation and altered collagen matrix.

Purpose of the Study:

• To review recent insights into the mechanisms of myocardial structural remodeling in heart failure.
• To identify novel therapeutic targets for preventing or reversing pathological remodeling.
• To explore future therapeutic strategies based on experimental and pilot clinical studies.

Main Methods:

• Review of experimental studies on myocardial remodeling.
• Analysis of pilot clinical studies investigating novel therapeutic targets.
• Examination of mechanisms governing cardiomyocyte growth/death, inflammation, and matrix alterations.

Main Results:

• Growing knowledge of remodeling mechanisms enhances understanding of current therapies.
• New therapeutic targets identified for intervention in inflammation and matrix alterations.
• Potential to develop strategies to prevent or reverse cardiomyocyte death.

Conclusions:

• Direct intervention on pathological myocardial remodeling represents a paradigm shift in heart failure therapy.
• Understanding the complex interplay of remodeling mechanisms is crucial for developing effective treatments.
• Future therapies may focus on reversing inflammation, matrix changes, and cardiomyocyte death to improve cardiac function.